The pregnant women living with hiv antiretroviral therapy coverage for pmtct of Guinea-Bissau is still 60%, with no variation since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Guinea-Bissau
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Guinea-Bissau
PMTCT antiretroviral therapy coverage
More indicators for Guinea-Bissau
Male unintentional poisoning
3.0
-0.1
(2019)
Female wasting in children
4.5%
-1.1%
(2019)
Female prevalence of HIV
0.9%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar104
+intl dollar2
(2021)
Birth registration
46%
+22.3%
(2019)
Contraceptive modern method prevalence
20.2%
+5.8%
(2019)
Guinea-Bissau PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 60% | 0% |
| 2021 | 60% | -20% |
| 2020 | 80% | +1% |
| 2019 | 79% | +14% |
| 2018 | 65% | -22% |
| 2017 | 87% | 0% |
| 2016 | 87% | -2% |
| 2015 | 89% | -11% |
| 2014 | 100% | +39% |
| 2013 | 61% | +24% |
| 2012 | 37% | +13% |
| 2011 | 24% | +7% |
| 2010 | 17% | +6% |
| 2009 | 11% | +7% |
| 2008 | 4% | -4% |
| 2007 | 8% | 0% |
| 2006 | 8% | +8% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |